POLD2 and bladder transitional cell carcinoma: When CAD and POLD2 were examined for their association with drug response data in BLCA [10], CAD expression associated with resistance to systemic chemotherapy (P = 4.93e-4; Figure 5A), but this did not hold true for POLD2 (P = 0.318; Figure 5B).